Back to search

Article

IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancer

2023-02-14

Abstract excerpt

<title>Abstract</title> <p>Background Immunotherapy has dramatically changed the landscape of treatment for colorectal cancer (CRC), but there is lack of effective predictive biomarker, especially for tumors with mismatch repair (MMR) proficiency. Immune response relies to cell surface receptors and their interactions, such as cell-cell recognition, binding and adhesion. However, the function of immunoglobulin s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c02d0672-8063-52e0-935e-dc7ffdf8d566
DOI
10.21203/rs.3.rs-2194686/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancerDOI 10.21203/rs.3.rs-2194686/v2
IGSF6 is a biomarker associated with anti-tumor immune response in lung adenocarcinomaSemantic proximity
Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarkerSemantic proximity
Construction and evaluation of a prognostic risk model of DNA mismatch repair related genes in colorectal cancerSemantic proximity
Immunoglobulin superfamily 6-mediated immune signature determines prognosis and immune landscape in lung adenocarcinomaSemantic proximity
Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D.Semantic proximity
Constructing Immune Related Prognosis Score Based on Signatures to Predict the Benefit of Immunotherapy in Colorectal CancerSemantic proximity
IGSF6 is a prognostic biomarker associated with the anti-tumor activity of macrophages in lung adenocarcinomaSemantic proximity
SLAMF6 appears bidirectional in immune regulation of different cancersSemantic proximity
Interleukin-6-Positive Immune Cells as a Possible New Immunologic Marker Associated With the Colorectal Cancer Prognosis.Semantic proximity
Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancerSemantic proximity
Identification of DNA Repair-related Genes as Biomarkers Reflecting MSI, TMB, and TIL in Colorectal Cancer.Semantic proximity
JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancerSemantic proximity
Select a neighboring publication to make it the new centre.